Jessica Hagen

VSee's telehealth SaaS platform will power the Ava robot, which aims to allow remote providers to be present at an ICU patient's bedside.

The New York-based company's stock price fell upon news of a 2% decrease in second-quarter revenue and a $837.7 million net loss.

The Act is the world's first major law for AI implementation and provides regulations for high-risk applications of the technology, including its use in healthcare.

The women's health app will use the funds to expand its workforce in North America and Europe, scale its reach and enhance its technology.

The funding announcement comes just one year after the company secured a $71 million investment.

Sigsense leverages AI to help lab managers better understand how lab instruments are used and how to optimize them for efficiency.

ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.

The company will use the funds to accelerate its growth and build its product offerings.

Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.

The companies will build foundation models and genAI applications aimed at improving patient care and medical diagnostics.